3Bakker K, Schaper NC. The development of global consensusguidelines on the management and prevention of the diabeticfoot 2011[J]. Diabetes Metab Res Rev, 2012,28 Suppl 1 :S116-118. DOI: 10.1002/dmrr.2254.
4Graziani L, Silvestro A, Bertone V, et al. Vascularinvolvement in diabetic subjects with ischemic foot ulcer: anew morphologic categorization of disease severity[J]. Eur JVase Endovasc Surg, 2007,33(4):453- 460. DOI: 10.1016/j.ejvs.2006.11.022.
8Loots MA, Lamme EN, Mekkes JR, et al. Cultured fibroblastsfrom chronic diabetic wounds on the lower extremity (non-insuline- dependent diabetes mellitus) show disturbedproliferationfj]. Arch Dermatol Res, 1999,291 (2-3):93-99.
9Piazuelo E, Jimenez P, Lanas A,et al. Platelet-derived growthfactor and epidermal growth factor play a major role in humancolonic fibroblast repair activities[Jj. Eur Surg Res, 2000,32(3):191-196.
2[3]Sanz GS,Santos HX,lzquierdo HA,et al.Experimental model for local application of growth factors in skin re-epithelialisation[J].Scand J Plast Reconstr Surg Hand Surg,2000,34(3):199-206.
6Grana X;ReddyEP.Cell cycle control in mammalian cells: Role of cyclins,cyclin dependent kinases (CDKs),growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs),1995(02).
7Sherr CJ.D-type cyclins[J],1995(5).
8Falanga V;Margolis D;Alarez O.Rapid healing of venous ulcer and lack of clinical rejection with an allogenic cultured human skin equivalent[J],1997.
9Andreassi L.History of keratinocyte cultivation,1992(Suppl 1).
